A NEW SERUM BIOMARKER TO PREDICT THE RISK OF PROSTATE CANCER AT BIOPSY: PENTRAXIN-3

被引：0
|
作者：
Busetto, Gian Maria
Falagario, Ugo Giovanni
Netti, Giuseppe Stefano
Selvaggio, Oscar
Sanguedolce, Francesca
Ranieri, Elena
Bettocchi, Carlo
Carrieri, Giuseppe
Cormio, Luigi
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP45-01
引用
收藏
页码：E762 / E762
页数：1
相关论文
共 50 条
  • [1] Pentraxin-3: A novel serum biomarker to predict the risk of prostate cancer in patients submitted to prostate biopsy
    Busetto, G. M.
    Falagario, U. G.
    Netti, G. S.
    Selvaggio, O.
    Sanguedolce, F.
    Ranieri, E.
    Bettocchi, C.
    Carrieri, G.
    Cormio, L.
    EUROPEAN UROLOGY, 2022, 81 : S737 - S737
  • [2] Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy
    Falagario, Ugo Giovanni
    Busetto, Gian Maria
    Netti, Giuseppe Stefano
    Sanguedolce, Francesca
    Selvaggio, Oscar
    Infante, Barbara
    Ranieri, Elena
    Stallone, Giovanni
    Carrieri, Giuseppe
    Cormio, Luigi
    CANCERS, 2021, 13 (07)
  • [3] Modulation of complement activation by pentraxin-3 in prostate cancer
    Giovanni Stallone
    Giuseppe Stefano Netti
    Luigi Cormio
    Giuseppe Castellano
    Barbara Infante
    Paola Pontrelli
    Chiara Divella
    Oscar Selvaggio
    Federica Spadaccino
    Elena Ranieri
    Francesca Sanguedolce
    Antonio Pennella
    Loreto Gesualdo
    Giuseppe Carrieri
    Giuseppe Grandaliano
    Scientific Reports, 10
  • [4] Modulation of complement activation by pentraxin-3 in prostate cancer
    Stallone, Giovanni
    Netti, Giuseppe Stefano
    Cormio, Luigi
    Castellano, Giuseppe
    Infante, Barbara
    Pontrelli, Paola
    Divella, Chiara
    Selvaggio, Oscar
    Spadaccino, Federica
    Ranieri, Elena
    Sanguedolce, Francesca
    Pennella, Antonio
    Gesualdo, Loreto
    Carrieri, Giuseppe
    Grandaliano, Giuseppe
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [5] Serum pentraxin-3 as a potential biomarker for diagnosis and prognosis in primary liver cancer: An observational study
    Chen, Li
    Song, Shifu
    Chen, Mao
    Liu, Qin
    Zhou, Hongchi
    MEDICINE, 2024, 103 (50)
  • [6] Pentraxin-3 Is a Novel Biomarker of Lung Carcinoma
    Diamandis, Eleftherios P.
    Goodglick, Lee
    Planque, Chris
    Thomquist, Mark D.
    CLINICAL CANCER RESEARCH, 2011, 17 (08) : 2395 - 2399
  • [7] SERUM PENTRAXIN-3 IN THE ASSESSMENT OF CARDIOVASCULAR RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Targonska-Stepniak, B.
    Piotrowski, M.
    Zwolak, R.
    Majdan, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 251 - 251
  • [8] ASSOCIATION OF SERUM PENTRAXIN-3 LEVEL AND CARDIOVASCULAR RISK IN HEMODIALYSIS PATIENTS
    Salama, Maha
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [9] Is the Level of Pentraxin-3 a Valid Biomarker in Axial Spondyloarthritis?
    Orucoglu, Nurdan
    Balci-Fidanci, Senay
    Tamer, Lulufer
    AKTUELLE RHEUMATOLOGIE, 2023, 48 (05) : 355 - 360
  • [10] The role of pentraxin-3 as a prognostic biomarker in paraquat poisoning
    Yeo, Chang-Dong
    Kim, Jin-Woo
    Kim, Young-Ok
    Yoon, Sun-Ae
    Kim, Kwan-Hyoung
    Kim, Young-Soo
    TOXICOLOGY LETTERS, 2012, 212 (02) : 157 - 160
12345